The use of hip arthroplasty surgery has increased with time ([@CIT0020], [@CIT0029], [@CIT0026]) as the population ages and patients with more comorbidity and of older age are accepted for surgery. The need for surveillance of long-term results was recognized early, leading to the establishment of national registries. The Swedish Hip Arthroplasty Register was established in 1979, followed by the Finnish equivalent in 1980, and the Norwegian equivalent in 1987.

In one recent publication on trends in primary hip arthroplasty in the USA from 1990 to 2004, an overall decrease in procedure-related complications and adverse diagnoses was seen, although at the same time an increase in the prevalence of comorbidities took place ([@CIT0025]). Herberts and Malchau found a decrease in revision with time in the Swedish population after hip arthroplasty ([@CIT0018]).

We evaluated the results of hip arthroplasty, with particular focus on time trends, during the period 1987 through 2007. Overall revision and also revision due to specific causes such as loosening of components, dislocation, or infection were studied. We also studied the timing of an event in relation to the primary operation for given causes of revision, and compared 4 time periods.

Patients and methods {#ss2}
====================

We used data from the Norwegian Arthroplasty Register (NAR), which is a population-based prospective database ([@CIT0016]). All hospitals in Norway at which the procedure is performed (n = 64 in 2007) report to the NAR. Data concerning patient identification, diagnosis, date of surgery, whether the operation was primary or a revision, type of prosthesis, whether cement was used and type of cement, and the use of antibiotics, is derived from a form filled in by the operating surgeon ([@CIT0011]). Furthermore, the causes of revision and the procedures performed at revision are reported. In a study from 2006 comparing data from the NAR to the official patient administration system, the data in the NAR were found to be complete ([@CIT0008]).

In the present article these data were used to study changes in the rate of revision arthroplasty after primary surgery, over a 21-year period from 1987 through 2007. The patients were divided into four groups according to the year of primary surgery: 1987--1992, 1993--1997, 1998--2002, and 2003--2007. The first period, from 1987 through 1992, was used as the reference period.

From 1987 through 2007, 110,882 primary total hip replacements were reported to the NAR ([Table 1](#T1){ref-type="table"}). For the analyses, patients were defined as having osteoarthritis (OA) or not (patients with all other diagnoses), and the analyses were adjusted for diagnosis, sex, and age.

###### 

Age, sex, and diagnosis at primary surgery in 4 time periods

                                        All           1987--1992    1993--1997    1998--2002    2003--2007
  ------------------------------------- ------------- ------------- ------------- ------------- -------------
  Mean age                              69            69            70            70            70
  Sex (% women)                         70            70            70            70            69
  n                                     110,882       24,651        24,659        28,817        32,755
  Diagnosis                                                                                     
   Osteoarthritis                       79,700 (72)   16,597 (67)   17,130 (70)   20,976 (73)   24,997 (76)
   Rheumatoid arthritis                 3,465 (3.1)   942 (3.8)     902 (3.7)     851 (3.0)     770 (2.4)
   Sequelae after fracture              11,933 (11)   3,299 (13)    3,133 (13)    2,886 (10)    2,615 (8)
   Sequelae dysplasia                   8,125 (7.3)   2,037 (8.3)   1,795 (7.3)   2,032 (7.1)   2,261 (6.9)
   Sequelae dysplasia, total luxation   879 (0.8)     414 (1.7)     214 (0.9)     141 (0.5)     110 (0.3)
  Sequelae Perthes\'/epiphysiolysis     1,442 (1.3)   319 (1.3)     329 (1.3)     388 (1.3)     406 (1.2)
  Ankylosing spondylitis                477 (0.4)     105 (0.4)     116 (0.5)     144 (0.5)     112 (0.3)
  Acute fracture                        969 (0.9)     55 (0.2)      116 (0.5)     233 (0.8)     565 (1.7)

During the study period, 99 different femur implants, 85 different acetabular implants, and 70 different caput implants were used in Norway ([Table 2](#T2){ref-type="table"}). The 45 most common implant types used during the study period were published in the annual report from the NAR (<http://www.haukeland.no/nrl/eng/>, 2008). The Charnley prosthesis (DePuy, Leeds, UK) was the most common implant during the study period and the original monoblock Charnley prosthesis was used throughout the study period.

###### 

The most commonly used implants, in 4 time periods

  Most commonly used             1987--1992   1993--1997   1998--2002   2003 and later   Total
  ------------------------------ ------------ ------------ ------------ ---------------- --------
  a\. Acetabular implants                                                                
   Charnley (DePuy)              11,947       11,789       10,431       7,270            41,437
   Exeter (Stryker)              2,609        2,029        2,866        3,871            11,375
   Reflection (Smith & Nephew)   0            818          3,505        6,613            10,936
   Titan (DePuy)                 1,903        2,262        1,861        1,884            7,910
   Elite (DePuy)                 597          409          1,261        2,950            5,217
   Tropic (DePuy)                1,065        1,443        1,232        82               3,822
   Spectron (Smith & Nephew)     2,128        1,117        406          0                3,651
   Trilogy (Zimmer)              0            381          1,012        1,517            2,910
   SP (Link)                     474          393          776          1,211            2,854
  b\. Femoral implants                                                                   
   Charnley (DePuy)              12,556       12,291       10,039       6,323            41,209
   Exeter (Stryker)              2,652        2,090        3,163        6,304            14,209
   Titan (DePuy)                 2,669        2,776        3,069        2,913            11,427
   Corail (DePuy)                1,096        2,232        2,107        3,392            8,827
   Spectron (Smith & Nephew)     51           183          2,552        5,971            8,757
   ITH (Smith & Nephew)          1,230        1,446        983          64               3,723
   SP (Link)                     1            394          582          1,128            2,105
  c\. Caput implants                                                                     
   Exeter (Stryker)              2,269        2,088        3,206        6,598            14,161
   Universal (Smith & Nephew)    1,652        2,475        3,705        5,898            13,730
   Landos (Ortho Medic)          3,824        5,037        2,527        2,566            13,954
   Fjord (Ortho Medic)           0            392          2,841        3,431            6,664
   SP II Lubinus (Link)          0            388          584          1130             2,102

In prostheses with a cemented femoral component, the caput was modular in 52,371 cases while in 46,447 cases a monoblock femoral component was used. Of the uncemented femoral components, 22,412 modular caput components were used as opposed to only 67 monoblocks.

A prosthesis in which a cemented femoral component and an uncemented acetabular component was used was defined as a hybrid prosthesis, while inverse hybrid was the term used for a prosthesis with an uncemented femoral component and a cemented acetabular component. 23 different cement types were used. These included several variants of the Palacos (Heraeus Medical, Germany; Schering-Plough; Biomet) and Simplex (Howmedica, UK; Stryker) cements, which, for the purposes of this article, are analyzed together.

A revision was defined as the removal or exchange of a part of or the whole implant. On the forms, several causes of revision could be given for the same patient. However, in the present study only one cause was selected for each patient. This was done by a fixed system of priority; for instance, deep infection was selected when it was one of many causes, and pain was only selected when it was the only given cause of revision. Overall revision was defined as revision for any cause.

Statistics {#ss3}
----------

Information on death or emigration was obtained from Statistics Norway. The patients were followed until time of revision, death, or emigration, or until the end of the study (December 31, 2007), at which point the patients were censored.

Analyses of overall revision (revision for any cause) were done for all prostheses together and separately for cemented, hybrid, inverse hybrid, and uncemented prostheses. A rather homogenous group of patients (n = 28,225) with a Charnley prosthesis cemented with Simplex or Palacos cements was selected in order to investigate possible changes that could not be attributed to changes in implant or cement type. Separate analyses were performed for this group, as well as for a group of all other cemented implants. Charnley prostheses and Palacos and Simplex cements were chosen since they are well documented and have shown good results ([@CIT0021], [@CIT0028], Havelin et al. 1995, [@CIT0010], [@CIT0007], [@CIT0009]).

Kaplan-Meier survival plots were used to compare cumulative prosthesis survival between subgroups of patients (i.e. patients operated during the 4 time periods). The overall risk of revision and the risk of revision due to specific causes (deep infection, dislocation, or aseptic loosening of the femoral or acetabular component) were calculated using Cox regression analyses. The risk estimates were adjusted for age, sex, and diagnosis. Based on figures for scaled Schoenfeld residuals showing an increased relative risk during the first postoperative year, Cox analyses with time-dependent covariates, with indicators before/after the first postoperative year, were performed. Thus, risk of revision within the first year was compared between the different time periods using Cox regression analysis with time-dependent covariates, as was the risk of revision after the first year ([Table 5](#T5){ref-type="table"}). All analyses were performed using SPSS software version 17.0.

Results {#ss4}
=======

During the 21-year period, the sex distribution and mean age of the patients remained largely unchanged ([Table 1](#T1){ref-type="table"}). Subanalyses of age within the group of patients with osteoarthritis showed that the mean age remained the same during the 4 time periods, but the age distribution broadened, with more younger and more older patients operated during the later periods. The cause of arthroplasty changed towards more patients with osteoarthritis and fewer with rheumatoid arthritis and sequelae after fracture ([Table 1](#T1){ref-type="table"}). Furthermore, there was a change in the types of implant used during the study period, with a decrease in Charnley prostheses in parallel with an increase in the use of Exeter and Spectron femoral components and Reflection cups being the most prominent changes ([Table 2a](#T2){ref-type="table"} and [b](#T2){ref-type="table"}). The use of modular caput implants increased in general, and for all the common implant brands ([Table 2c](#T2){ref-type="table"}). No marked change in the use of cemented versus uncemented prostheses occurred, although there was an increase in the use of inverse hybrid prostheses (with cementation of the acetabular component) ([Table 3](#T3){ref-type="table"}). The use of the high-viscosity cements Simplex and Palacos---and also cements closely resembling Palacos (Refobacin bone cement R)---increased throughout the study period ([Figure 1](#F1){ref-type="fig"}).

###### 

Fixation method for 4 time periods

                                                    1987--1992     1993--1997     1998--2002     2003 and later   Total
  ------------------------------------------------- -------------- -------------- -------------- ---------------- ------------------------------------------------
  Cemented                                          19,837 (82)    19,833 (81)    23,161 (81)    24,104 (75)      86,935 (79)
  Uncemented                                        3,142 (13)     3,355 (14)     3,715 (13)     4,410 (14)       14,622 (13)
  Hybrid [^**b**^](#T3-N2){ref-type="fn"}           1,028 (4.3)    1,317 (5.4)    1,363 (4.7)    684 (2.1)        4,392 (4.0)
  Inverse hybrid [^**c**^](#T3-N3){ref-type="fn"}   60 (0.2)       45 (0.2)       482 (1.7)      3,140 (9.7)      3,727 (3.4)
  Total                                             24,067 (100)   24,550 (100)   28,721 (100)   32,338 (100)     109,676 (100) [**^a^**](#T3-N1){ref-type="fn"}

**^a^** The fixation method was not reported for 1,206 prostheses.

**^b^** Hybrid means cemented femur component and uncemented cup.

**^c^** Inverse hybrid means uncemented femur component and cemented cup.

![Number of hips inserted using Simplex, Palacos, or cement types resembling Palacos (green), in 4 time periods. Blue represents other cement types.](ORT-0300-9734-081-649_g001){#F1}

The major cause of revision was aseptic loosening of one or both implant components, seen in 5,328 cases and constituting 66% of all revision operations ([Table 4](#T4){ref-type="table"}). Other major causes of revision were dislocation, infection, and pain, constituting 14.5, 8.7, and 8.3 per cent (2.2 with pain as the only cause) of the revisions, respectively ([Table 4](#T4){ref-type="table"}). A decline in the number of revisions took place throughout the study period, for all causes of revision except dislocation and infection ([Figure 2](#F2){ref-type="fig"}).

###### 

Numbers of revisions due to specific causes for the 4 time periods

  Cause of revision                                        All                                          1987--1992   1993--1997   1998--2002   2003--2007
  -------------------------------------------------------- -------------------------------------------- ------------ ------------ ------------ ------------
  Loose femur [**^a^**](#T4-N1){ref-type="fn"}             3,522                                        1,936        1,175        325          86
  Loose acetabulum [**^a^**](#T4-N1){ref-type="fn"}        3,043                                        1,789        868          313          73
  Aseptic loosening [**^b^**](#T4-N2){ref-type="fn"}       5,328                                        2,984        1,681        526          137
  Dislocation                                              1,177                                        258          333          338          248
  Infection                                                706                                          160          175          168          203
  Fracture                                                 392                                          164          123          62           43
  Pain                                                     668 (175 [**^e^**](#T4-N5){ref-type="fn"})   319          220          91           38
  Osteolysis acetabulum [**^c^**](#T4-N3){ref-type="fn"}   266                                          130          109          23           4
  Osteolysis femur [**^c^**](#T4-N3){ref-type="fn"}        301                                          163          109          26           3
  Total [^**d**^](#T4-N4){ref-type="fn"}                   8,094                                        3,806        2,504        1,125        659

**^a^** Aseptic loosening of one component.

**^b^** Aseptic loosening of one or both components.

**^c^** Osteolysis without loosening.

**^d^** More than one cause of revision may be reported; thus, the sum of the different causes does not equal the total number of revision procedures.

**^e^** In 175 patients, pain was the only reported cause of revision.

![Numbers of revisions for different causes, in 4 time periods.](ORT-0300-9734-081-649_g002){#F2}

When considering overall revision (i.e. for any cause) for all types of hip implants together, the risk of revision for patients operated during the second, third, and fourth time periods was lower than for those operated during the reference period ([Figure 3a](#F3){ref-type="fig"}) (RR = 0.51 (95% CI: 0.47--0.55) for 1998--2002 compared to 1987--1992). Early revision, i.e. revision within the first postoperative year, was more frequent in the 3 later time periods (p \< 0.001), while the opposite was seen for revisions that took place after the first year (p \< 0.001) ([Table 5a](#T5){ref-type="table"}, first column). This indicates that although the revision rate was falling, revision surgery took place more rapidly after the primary operation in the later periods.

![Kaplan-Meier survival plots. Revision for any cause in 4 time periods. A. All prostheses. B. All cemented prostheses. C. All uncemented prostheses. D. All hybrid prostheses.](ORT-0300-9734-081-649_g003){#F3}

###### 

Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral component, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). All prostheses, n = 101,550

  A              B                        C                        D                        E                        F              
  -------------- -------------- --------- -------------- --------- -------------- --------- -------------- --------- -------------- ---------
  Total                                                                                                                             
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    0.81           \<0.001   0.69           \<0.001   0.67           \<0.001   1.58           \<0.001   1.18           0.2
                 (0.77--0.86)             (0.63--0.75)             (0.62--0.72)             (1.32--1.90)             (0.94--1.47)   
   1998--2002    0.51           \<0.001   0.43           \<0.001   0.23           \<0.001   1.87           \<0.001   1.11           0.4
                 (0.47--0.55)             (0.37--0.49)             (0.20--0.26)             (1.56--2.26)             (0.88--1.40)   
   2003--2007    0.77           \<0.001   0.36           \<0.001   0.19           \<0.001   2.21           \<0.001   2.13           \<0.001
                 (0.68--0.85)             (0.28--0.47)             (0.15--0.24)             (1.80--2.72)             (1.69--2.68)   
  First year                                                                                                                        
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    1.48           \<0.001   1.02           1.0       0.83           0.4       2.22           \<0.001   1.99           0.01
                 (1.19--1.84)             (0.59--1.75)             (0.54--1.27)             (1.56--3.16)             (1.17--3.41)   
   1998--2002    1.64           \<0.001   0.89           0.7       0.37           \<0.001   2.81           \<0.001   2.05           0.007
                 (1.33--2.03)             (0.52--1.54)             (0.22--0.63)             (2.01--3.93)             (1.21--3.46)   
   2003--2007    2.09           \<0.001   0.51           0.04      0.37           \<0.001   2.88           \<0.001   4.60           \<0.001
                 (1.71--2.56)             (0.27--0.98)             (0.22--0.63)             (2.06--4.03)             (2.85--7.41)   
  After 1 year                                                                                                                      
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    0.78           \<0.001   0.68           \<0.001   0.66           \<0.001   1.39           0.002     1.04           0.8
                 (0.74--0.83)             (0.63--0.75)             (0.61--0.72)             (1.13--1.72)             (0.80--1.33)   
   1998--2002    0.42           \<0.001   0.41           \<0.001   0.22           \<0.001   1.51           \<0.001   0.93           0.6
                 (0.39--0.46)             (0.36--0.47)             (0.19--0.25)             (1.20--1.91)             (0.71--1.22)   
   2003--2007    0.54           \<0.001   0.36           \<0.001   0.17           \<0.001   2.09           \<0.001   1.44           0.02
                 (0.47--0.62)             (0.27--0.48)             (0.13--0.22)             (1.55--2.83)             (1.06--1.94)   

A Time period

B All revisions RR (95% CI) and p--value

C Acetabular loosening RR (95% CI) and p--value

D Femoral loosening RR (95% CI) and p--value

E Dislocation RR (95% CI) and p--value

F Infection RR (95% CI) and p--value

Still considering all types of hip implants, the reduction in revisions was due to a statistically significant fall in revisions caused by acetabular or femoral component loosening ([Table 5a](#T5){ref-type="table"}, second and third columns). For these 2 major causes of revision, no increase in revision within the first postoperative year was seen. The trend was opposite when considering revision due to dislocation, with an overall increase in revisions due to dislocation throughout the study period, with a greater increase in procedures taking place within the first postoperative year, but also after the first year ([Table 5a](#T5){ref-type="table"}, column 4). A similar trend was seen for revisions due to infection, although it was less evident---except for the period 2003--2007 ([Table 5a](#T5){ref-type="table"}, column 5).

When analyzing all cemented prostheses separately, the results were very much the same as for all prostheses analyzed together, with an improved overall revision rate ([Figure 3b](#F3){ref-type="fig"}) and particularly less revisions due to aseptic loosening ([Table 5b](#T6){ref-type="table"}, columns 1, 2, and 3). As was seen in the total group, there were more early revisions and less late revisions during the last 3 time periods. The risk of revision due to dislocation increased during the 3 later time periods, particularly revision procedures performed within the first postoperative year ([Table 5b](#T6){ref-type="table"}, column 4). Furthermore, revisions due to deep infection increased, as was seen for the total group ([Table 5b](#T6){ref-type="table"}, column 5).

###### 

Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral component, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). All cemented prostheses, n = 86,929

  A              B                        C                        D                        E                        F              
  -------------- -------------- --------- -------------- --------- -------------- --------- -------------- --------- -------------- ---------
  Total                                                                                                                             
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    0.92           0.01      0.87           0.012     0.81           \<0.001   1.57           \<0.001   1.17           0.2
                 (0.86--0.98)             (0.78--0.97)             (0.75--0.88)             (1.28--1.92)             (0.91--1.49)   
   1998--2002    0.59           \<0.001   0.64           \<0.001   0.25           \<0.001   2.01           \<0.001   1.07           0.6
                 (0.54--0.64)             (0.55--0.74)             (0.22--0.29)             (1.63--2.47)             (0.83--1.37)   
   2003--2007    0.72           \<0.001   0.40           \<0.001   0.17           \<0.001   2.20           \<0.001   1.82           \<0.001
                 (0.65--0.81)             (0.30--0.54)             (0.13--0.22)             (1.74--2.77)             (1.41--2.34)   
  First year                                                                                                                        
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    1.72           \<0.001   1.00           1.0       1.08           0.8       2.64           \<0.001   2.03           0.01
                 (1.34--2.21)             (0.56--1.79)             (0.67--1.74)             (1.74--3.99)             (1.17--3.52)   
   1998--2002    1.84           \<0.001   0.90           0.7       0.45           0.007     3.51           \<0.001   1.84           0.03
                 (1.44--2.34)             (0.51--1.60)             (0.25--0.81)             (2.37--5.21)             (1.07--3.18)   
   2003--2007    2.01           \<0.001   0.36           0.009     0.20           \<0.001   3.26           \<0.001   3.85           \<0.001
                 (1.58--2.54)             (0.17--0.77)             (0.09--0.45)             (2.19--4.85)             (2.34--6.34)   
  After 1 year                                                                                                                      
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    0.87           \<0.001   0.86           0.01      0.80           \<0.001   1.29           0.04      1.01           1.0
                 (0.81--0.94)             (0.77--0.97)             (0.74--0.87)             (1.02--1.64)             (0.76--1.32)   
   1998--2002    0.49           \<0.001   0.62           \<0.001   0.25           \<0.001   1.53           0.001     0.91           0.5
                 (0.45--0.54)             (0.54--0.73)             (0.21--0.28)             (1.18--1.99)             (0.68--1.21)   
   2003--2007    0.52           \<0.001   0.42           \<0.001   0.17           \<0.001   2.02           \<0.001   1.23           0.2
                 (0.44--0.60)             (0.31--0.58)             (0.13--0.23)             (1.44--2.81)             (0.88--1.71)   

A--F, see [Table 5a](#T5){ref-type="table"}.

Patients with cemented Charnley prostheses (with Palacos or Simplex cement) had a better overall survival compared to those with uncemented, hybrid, inverse hybrid, and non-Charnley cemented prostheses (p \< 0.001) ([Figure 4a](#F4){ref-type="fig"}), a finding that was less prominent but still present during the last 10-year period (p\<0.001) ([Figure 4b](#F4){ref-type="fig"}). In the 1,206 patients for whom the fixation method was unknown, the results closely resembled those of the hybride group (not included in [Figure 4](#F4){ref-type="fig"}). In the adjusted analysis, overall revision rate for the Charnley group increased during the second period compared to the first, while a statistically significant decrease in revision was seen in the third period, with a similar trend during the fourth one ([Table 5c](#T7){ref-type="table"}, column 1). Revisions performed within the first year were more common during all the 3 later periods, while the opposite was seen for revisions after the first year (except in the second time period).

![Kaplan-Meier survival plot. Revision for any cause. A. 1987--2007. B. 1998--2007.](ORT-0300-9734-081-649_g004){#F4}

###### 

Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral component, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). Charnley prostheses with Palacos or Simplex cement, n = 28,225

  A              B                        C                        D                        E                        F              
  -------------- -------------- --------- -------------- --------- -------------- --------- -------------- --------- -------------- -------
  Total                                                                                                                             
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    1.27           \<0.001   1.12           0.3       1.28           0.001     1.75           0.002     1.15           0.5
                 (1.13--1.44)             (0.89--1.40)             (1.11--1.49)             (1.23--2.50)             (0.78--1.70)   
   1998--2002    0.61           \<0.001   0.44           \<0.001   0.21           \<0.001   2.21           \<0.001   0.88           0.6
                 (0.51--0.72)             (0.30--0.63)             (0.15--0.28)             (1.54--3.18)             (0.58--1.35)   
   2003--2007    0.88           0.3       0.31           0.003     0.25           \<0.001   2.61           \<0.001   1.76           0.02
                 (0.70--1.12)             (0.14--0.67)             (0.14--0.45)             (1.68--4.07)             (1.11--2.79)   
  First year                                                                                                                        
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    2.01           0.002     0.97           1.0       1.10           0.8       2.78           0.003     1.49           0.3
                 (1.30--3.09)             (0.33--2.89)             (0.46--2.61)             (1.42--5.45)             (0.66--3.34)   
   1998--2002    2.00           0.002     0.91           0.9       0.61           0.3       3.30           \<0.001   1.50           
                 (1.23--3.07)             (0.31--2.72)             (0.23--1.63)             (1.71--6.39)             (0.68--3.35)   
   2003--2007    2.31           \<0.001   0.24           0.2       0.17           0.09      3.63           \<0.001   2.89           0.01
                 (1.45--3.68)             (0.03--2.02)             (0.021.30)               (1.79--7.40)             (1.30--6.43)   
  After 1 year                                                                                                                      
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    1.22           0.002     1.13           0.3       1.29           0.001     1.42           0.1       1.06           0\. 8
                 (1.07--1.39)             (0.89--1.42)             (1.11--1.50)             (0.93--2.17)             (0.68--1.66)   
   1998--2002    0.46           \<0.001   0.39           \<0.001   0.18           \<0.001   1.83           0.008     0.70           0.2
                 (0.38--0.56)             (0.26--0.58)             (0.13--0.26)             (1.17--2.87)             (0.41--1.17)   
   2003--2007    0.62           0.004     0.33           0.009     0.27           \<0.001   2.36           0.009     1.34           0.3
                 (0.45--0.86)             (0.14--0.76)             (0.15--0.48)             (1.24--4.50)             (0.74--2.45)   

A--F, see [Table 5a](#F5){ref-type="fig"}.

When considering revision due to aseptic loosening, the risk of revision within the first postoperative year remained unchanged throughout the study period, while a reduction in such revisions performed after the first postoperative year was seen after 1997 ([Table 5c](#T7){ref-type="table"}, columns 2 and 3). As for the total group, the risk of revision due to dislocation increased during the study period, but no significant change in the risk of revision due to deep infection was seen except for an increased risk in the period from 2003 through 2007 ([Table 5c](#T7){ref-type="table"}, columns 4 and 5).

The results after insertion of cemented prostheses other than Charnley were similar to those described for the total study group ([Table 5d](#T8){ref-type="table"}).

###### 

Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral component, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). Other cemented prostheses, n = 58,704

  A              B                        C                        D                        E                        F              
  -------------- -------------- --------- -------------- --------- -------------- --------- -------------- --------- -------------- ---------
  Total                                                                                                                             
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    0.83           \<0.001   0.86           0.02      0.68           \<0.001   1.50           0.002     1.15           0.4
                 (0.76--0.90)             (0.75--0.97)             (0.61--0.75)             (1.17--1.94)             (0.84--1.58)   
   1998--2002    0.60           \<0.001   0.72           \<0.001   0.27           \<0.001   1.94           \<0.001   1.17           0.3
                 (0.55--0.66)             (0.61--0.85)             (0.24--0.32)             (1.51--2.51)             (0.86--1.60)   
   2003--2007    0.67           \<0.001   0.41           \<0.001   0.15           \<0.001   2.08           \<0.001   1.90           \<0.001
                 (0.59--0.76)             (0.30--0.56)             (0.11--0.20)             (1.58--2.73)             (1.40--2.57)   
  First year                                                                                                                        
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    1.60           0.003     1.07           0.8       1.11           0.7       2.53           0.001     2.47           0.02
                 (1.17--2.19)             (0.54--2.14)             (0.62--1.98)             (1.49--4.29)             (1.16--5.25)   
   1998--2002    1.79           \<0.001   0.93           0.8       0.39           0.01      3.67           \<0.001   2.09           0.05
                 (1.34--2.40)             (0.47--1.81)             (0.19--0.81)             (2.25--5.99)             (0.99--4.40)   
   2003--2007    1.90           \<0.001   0.36           0.02      0.20           \<0.001   3.20           \<0.001   4.78           \<0.001
                 (1.43--2.50)             (0.16--0.84)             (0.08--0.49)             (1.97--5.20)             (2.46--9.31)   
  After 1 year                                                                                                                      
   1987--1992    1                        1                        1                        1                        1              
   1993--1997    0.79           \<0.001   0.85           0.02      0.67           \<0.001   1.26           0.1       0.96           0.8
                 (0.73--0.86)             (0.75--0.97)             (0.60--0.74)             (0.94--1.69)             (0.67--1.36)   
   1998--2002    0.52           \<0.001   0.71           \<0.001   0.27           \<0.001   1.41           0.04      1.03           0.9
                 (0.47--0.58)             (0.60--0.84)             (0.23--0.31)             (1.03--1.95)             (0.73--1.46)   
   2003--2007    0.48           \<0.001   0.43           \<0.001   0.14           \<0.001   1.88           0.002     1.20           0.4
                 (0.40--0.56)             (0.30--0.61)             (0.10--0.20)             (1.27--2.78)             (0.81--1.79)   

A--F, see [Table 5a](#T5){ref-type="table"}.

Uncemented prostheses (n = 14,621) generally had a worse prognosis than the cemented ones ([Figure 4a](#F4){ref-type="fig"}), but the results improved with time and the gap between cemented and uncemented implants narrowed ([Figure 4b](#F4){ref-type="fig"}). The regression analysis showed a reduction in overall revision with RR = 0.3 (95% CI: 0.25--0.35) when comparing the period 1998--2002 to the reference period ([Table 5e](#T9){ref-type="table"}, first column), also illustrated in [Figure 3c](#F3){ref-type="fig"}. However, the overall revision rate as well as revision due to component loosening increased during the last study period (2003--2007) compared to 1998--2002 ([Table 5e](#T9){ref-type="table"}, columns 1--3). Furthermore, the risk of dislocation increased in this prosthesis group as well as for the cemented ones, particularly during the last study period ([Table 5e](#T9){ref-type="table"}, column 4) and the risk of revision due to infection increased markedly in the last study period (RR = 5.5 (95% CI: 2.9--11).

###### 

Relative risk of overall revision (due to any cause), aseptic loosening of acetabular component, aseptic loosening of femoral component, dislocation, and infection adjusted for age sex, and diagnosis (OA vs. other). Uncemented prostheses, n = 14,621

  A              B                        C                        D                        E                       F               
  -------------- -------------- --------- -------------- --------- -------------- --------- --------------- ------- --------------- ---------
  Total                                                                                                                             
   1987--1992    1                        1                        1                        1                       1               
   1993--1997    0.61           \<0.001   0.46           \<0.001   0.16           \<0.001   1.56            0.02    1.31            0.4
                 (0.55--0.67)             (0.40--0.53)             (0.12--0.22)             (1.06--2.28)            (0.69--2.48)    
   1998--2002    0.30           \<0.001   0.09           \<0.001   0.11           \<0.001   1.28            0.3     1.51            0.4
                 (0.25--0.35)             (0.06--0.14)             (0.07--0.17)             (0.83--1.95)            (0.77--2.96)    0.2
   2003--2007    0.91           0.4       0.28           \<0.001   0.27           \<0.001   1.93            0.005   5.51            \<0.001
                 (0.75--1.11)             (0.15--0.52)             (0.17--0.45)             (1.22.--3.05)           (2.85--10.66)   
  First year                                                                                                                        
   1987--1992    1                        1                        1                        1                       1               
   1993--1997    0.87           0.6       1.26           0.8       0.34           0.04      1.25            0.5     1.85            0.6
                 (0.55--1.38)             (0.28--5.63)             (0.12--0.93)             (0.63--2.49)            (0.17--20.42)   
   1998--2002    1.04           0.9       0.59           0.6       0.19           0.01      1.15            0.7     6.00            0.09
                 (0.67--1.61)             (0.10--3.53)             (0.06--0.67)             (0.58--2.28)            (0.74--48.81)   
   2003--2007    2.08           \<0.001   1.41           0.6       0.75           0.5       1.68            0.1     18.07           0.005
                 (1.41--3.05)             (0.34--5.90)             (0.35--1.64)             (0.89--3.16)            (2.43--134.2)   
  After 1 year                                                                                                                      
   1987--1992    1                        1                        1                        1                       1               
   1993--1997    0.60           \<0.001   0.46           \<0.001   0.15           \<0.001   1.71            0.02    1.27            0.5
                 (0.54--0.66)             (0.40--0.53)             (0.11--0.21)             (1.08--2.70)            (0.65--2.46)    
   1998--2002    0.25           \<0.001   0.09           \<0.001   0.11           \<0.001   1.33            0.3     1.12            0.8
                 (0.20--0.30)             (0.06--0.13)             (0.07--0.17)             (0.78--2.28)            (0.53--2.37)    
   2003--2007    0.62           0.001     0.18           \<0.001   0.14           \<0.001   2.11            0.04    3.77            0.001
                 (0.47--0.83)             (0.08--0.42)             (0.07--0.31)             (1.04--2.27)            (1.70--8.38)    

A--F, see [Table 5a](#F5){ref-type="fig"}.

The use of hybrid prostheses decreased in the latest time period while the opposite was seen for inverse hybrids ([Table 3](#T3){ref-type="table"}). The survival curve for hybrids showed an improvement similar to that of other types, and even for the last time period, the development appeared to follow that of the previous time period with more early revisions and fewer late ones, although a longer follow-up period would be needed to ascertain this ([Figure 3d](#F3){ref-type="fig"}).

Kaplan-Meier survival curves for every hospital performing hip arthroplasties in Norway during the 2 time periods 1987--1997 and 1998--2007 showed a general improvement---leading to a narrower cluster of curves---with the mean survival for the latter time period being higher than for the first one ([Figure 5](#F5){ref-type="fig"}).

![Kaplan-Meier survival plot for cemented hip prostheses: every hospital in Norway in 2 time periods. A. 1987--1997. B. 1998--2008.](ORT-0300-9734-081-649_g005){#F5}

Discussion {#ss5}
==========

Our major finding was a general improvement in the results of hip replacement surgery during the 21-year period. This was seen for the total group as well as for all subgroups studied. Similar findings were reported from the Swedish Hip Registry ([@CIT0018]). However, in a recently published study on hip and knee arthroplasty in the USA performed 1990--2002, [@CIT0022] found a constant revision rate during the study period. The positive development in Norway was due to a fall in revisions for aseptic loosening, a finding that has also been reported from the Swedish register ([@CIT0019]).

An important cause of the improvement in results seen in our study can be attributed to the increasing use of well-documented implants with good results. We believe that the publication of registry studies pointing out inferior implants and cements has played an important role in this development. For example, articles from the NAR concerning the role of the cement type used for fixation were published in 1995, 1997, and in 2002 (Havelin et al. 1995, [@CIT0010], [@CIT0007]). In these studies, the superiority of high-viscosity cements was documented and use of the inferior Boneloc cement ceased as a result, as did the use of CMW cements. The benefit of antibiotic-loaded cement and prophylactic systemic antibiotics was also demonstrated in studies from the registry ([@CIT0006], [@CIT0005]). Courses in cementation technique may also have contributed to this improvement. Furthermore, certain brands of uncemented acetabular and femoral components have been shown to be associated with an increased risk of loosening (Havelin et al. 1995, Havelin et al. 1995, [@CIT0017], [@CIT0012]), which may have contributed to the improvement in the results of uncemented prostheses found in the period 1998--2002.

National registries provide valuable information on the epidemiology of specific diagnoses and/or treatments, treatment results, and time changes in treatment and results. The Norwegian Arthroplasty Register has data concerning hip arthroplasty from 1987 to the present. Data from the register is made public through annual reports, which are available on the internet ([www.haukeland.no/nrl](www.haukeland.no/nrl)). These data thus represent performance measurements for hip arthroplasty in Norway, which is important to surgeons regarding the choice of implant type, fixation method, surgical access, and the use of antibiotics. Furthermore, such information may be of use to health policy makers in providing information on present and future demands ([@CIT0023]), and also to the hospitals since results for each individual hospital (compared to all the others) are sent to all participating hospitals.

The positive development in terms of a declining revision rate was, however, also seen in the rather homogenous subgroup of Charnley implants inserted with Simplex or Palacos cement, although the improvement was not seen until the third time period (1998--2002). This indicates that improvement in surgical technique may also have played a part in the improvement in revision rate, which was indeed the intention when obligatory training programs in prosthesis surgery were initiated for surgeons in 1995. The Norwegian company selling the Charnley prosthesis also initiated training programs for surgeons in 1995, emphasizing modern cementing technique and the same company introduced new instruments for improved prosthesis placement.

In addition to the major finding of improved results during the 21-year study period, several other changes took place. The indication for inserting a hip implant changed, in that a gradual increase in the percentage of patients operated due to osteoarthritis was seen throughout the study period. Furthermore, the patients operated before 1993 were younger, which may, in part, be related to the first point. However, after 1993 the mean age remained stable. The percentage of patients operated due to osteoarthritis increased, but the mean age in this patient group remained the same due to the acceptance of both older patients and younger patients for hip replacement surgery. A change in the timing of revision surgery took place, with more early and fewer late revisions in the latter time periods. This might reflect a change in failure types, with more revisions due to dislocation and early infections and fewer late revisions due to aseptic loosening.

Another important trend was how the difference in results for the different hospitals diminished, giving a generally better hip arthroplasty service due to changes in the choice of implant brand, fixation method, and cement type. For instance, the use of inverse hybrid prostheses (with cementation of the acetabular component) increased, a method that gave better results than uncemented prostheses and the regular hybrids. The changes in implant and cement types and brands may, in part, have resulted from published results from register studies.

A newly published nationwide study from the USA has also found an increase over a 15-year period in the incidence of hip arthroplasties diagnosed with infection ([@CIT0024]). However, a British study of about 6,000 hip arthroplasties reported no change in the rate of prosthetic joint infections ([@CIT0027]). We found an increase in revisions due to deep infection that was most pronounced for uncemented prostheses. Hip prosthesis surgery in patients with more comorbidity, and more patients being on immunosuppressive drugs, may be plausible explanations for this development. For instance, obesity and diabetes are known risk factors for infection, and the incidences of both conditions are increasing in the population. In addition, an increased awareness of low-virulence infections may have caused more surgeons to be aware of this problem. Consequently, some revision operations that would previously have been designated "revision due to aseptic loosening" are now correctly characterized as infections. Changes in treatment policy, as described by Dale et al. in a recently published study from our registry, may also have influenced the risk of prosthesis infection ([@CIT0004]). For example, an increase in patients with higher ASA score was seen during the most recent years of the study (this factor was registered in the NAR from 2005), and higher ASA scores adversely influenced the rate of infection. On the other hand, antibiotic-loaded bone cement protects against infection ([@CIT0005], [@CIT0004]) and the increasing use of antibiotic-loaded cement thus tended to reduce the risk of revision due to infection.

In the large American study, dislocation was the most common cause of revision surgery ([@CIT0024]). In Norway, loosening of prosthesis components was by far the most frequent cause of revision, but the risk of revision caused by dislocation increased. More revisions due to dislocation may result from more young patients having hip implants, as they are more active. Increasing use of small femoral heads on modular prostheses has been shown to be associated with an increased risk of revision due to dislocation ([@CIT0003], [@CIT0002]). In the study by Bystrom et al. on data from the NAR, the use of 28-mm heads in the later period, compared to 32-mm heads previously, was found to be the main cause of the increase in revisions due to dislocation. From 2006, the use of 32-mm, 36-mm, and even larger head sizes has increased in both older and younger patients, in combination with the use of new bearing surfaces such as highly crosslinked polyethylene. Hopefully, this will contribute to a reduction in revisions due to dislocation in the future. Furthermore, the surgical approach has been shown to influence the risk of dislocation ([@CIT0002], [@CIT0001]). In the article by Arthursson et al. from Norway, the change from a lateral approach with trochanteric osteotomy to a lateral approach without trochanteric osteotomy contributed to the increase in dislocation rate for Charnley prostheses. Possible changes in treatment policy based on these findings might, in time, lead to a decline in the rate of revisions due to dislocation.

In conclusion, from 1987 through 2007, the revision rate after hip arthroplasty surgery decreased. The best results were obtained with the use of cemented prostheses, but the results of uncemented prostheses also improved throughout the study period. A change in the revision pattern took place, with more early revisions and less late revisions performed. There was an increase in revisions due to dislocation and infection.
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